Citation Impact
Citing Papers
Decision Curve Analysis: A Novel Method for Evaluating Prediction Models
2006 Standout
Recruitment of Follicles by Recombinant Human Follicle-Stimulating Hormone Commencing in the Luteal Phase of the Ovarian Cycle
1998
Regulation of the Human Menstrual Cycle
1998
Serum Bioactive and Immunoreactive Luteinizing Hormone and Follicle-Stimulating Hormone Levels in Women with Cycle Abnormalities, with or without Polycystic Ovarian Disease*
1991
Emerging Role of Lactobacilli in the Control and Maintenance of the Vaginal Bacterial Microflora
1990
Oral and pulmonary delivery of FSH–Fc fusion proteins via neonatal Fc receptor-mediated transcytosis
2005
Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen
1998
Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway
2006
A systematic review of tests predicting ovarian reserve and IVF outcome
2006
Exogenous Luteinizing Hormone (LH) Increases Estradiol Response Patterns in Poor Responders with Low Serum LH Concentrations
1999
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
The physiology and clinical utility of anti-Müllerian hormone in women
2014 Standout
Recurrent implantation failure: definition and management
2013 Standout
Single and Repeated GnRH Agonist Stimulation Tests Compared With Basal Markers of Ovarian Reserve in the Prediction of Outcome in IVF
2005
Polycystic Ovary Syndrome
1995 Standout
Müllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture
2007
Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men
1999
Vaginal Lactobacilli, Microbial Flora, and Risk of Human Immunodeficiency Virus Type 1 and Sexually Transmitted Disease Acquisition
1999 Standout
Contemporary Aspects of Discrete Peak-Detection Algorithms. II. The Paradigm of the Luteinizing Hormone Pulse Signal in Women*
1992
Derivation of Functional Antagonists Using N-Terminal Extracellular Domain of Gonadotropin and Thyrotropin Receptors
1997 StandoutNobel
Polycystic ovary syndrome
2016 Standout
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
2011 Standout
Co-expression of Defective Luteinizing Hormone Receptor Fragments Partially Reconstitutes Ligand-induced Signal Generation
1997 StandoutNobel
Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline
2017
FcRn: the neonatal Fc receptor comes of age
2007 Standout
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Transmembrane Regions V and VI of the Human Luteinizing Hormone Receptor Are Required for Constitutive Activation by a Mutation in the Third Intracellular Loop
1996 StandoutNobel
Mechanisms of implantation: strategies for successful pregnancy
2012 Standout
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Gut Microbiota in Health and Disease
2010 Standout
FSH-Releasing Hormone and LH-Releasing Hormone
1972 StandoutNobel
Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences
1997
Partnership status and the temporal context of relationships influence human female preferences for sexual dimorphism in male face shape
2002 Standout
Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles
2011
The hypothalamus and reproduction
1972 StandoutNobel
Granulosa Cells as Hormone Targets: The Role of Biologically Active Follicle-Stimulating Hormone in Reproduction
1989
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
2006
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Characterization of Functionally Typical and Atypical Types of Polycystic Ovary Syndrome
2009
Expression of Biologically Active Human Follitropin in Chinese Hamster Ovary Cells
1989
Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences*
1997
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Regulation of the human menstrual cycle
1971
Monomeric Fc Fusions
2006
Works of Jonas Harlin being referenced
Single-Dose Pharmacokinetics and Pharmacodynamics of Recombinant Human Follicle-Stimulating Hormone (Org 32489) in Gonadotropin-Deficient Volunteers
1998
Predictive power of clomiphene citrate challenge test for failure of in vitro fertilization treatment
2002
Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon ) in men with hypogonadotropic hypogonadism
1996
Endocrinology: Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women
1994
Serum Hormone Concentrations During Treatment with Multiple Rising Doses of Recombinant Follicle-Stimulating Hormone (Puregon) in Men with Hypogonadotropic Hypogonadism
1998
Molecular composition of luteinizing hormone and folliclestimulating hormone in commercial gonadotropin preparations
1986
Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489 ) in gonadotropin-deficient volunteers
1993
Qualitative and quantitative differences in the isoelectrofocusing profile of biologically active lutropin in the blood of normally menstruating and post-menopausal women
1981
Cervical bacterial flora in infertile and pregnant women
1978